← Mechanisms of action
20S proteosome
PROTEIN COMPLEXHomo sapiens
Linked proteins
- Proteasome subunit beta type-2 (PSMB2) ↗
- Proteasome subunit beta type-1 (PSMB1) ↗
- Proteasome subunit beta type-5 (PSMB5) ↗
- Proteasome subunit beta type-8 (PSMB8) ↗
- Proteasome subunit beta type-9 (PSMB9) ↗
- Proteasome subunit beta type-6 (PSMB6) ↗
- Proteasome subunit alpha-type 8 (PSMA8) ↗
- Proteasome subunit alpha type-1 (PSMA1) ↗
- Proteasome subunit alpha type-2 (PSMA2) ↗
- Proteasome subunit alpha type-3 (PSMA3) ↗
- Proteasome subunit alpha type-4 (PSMA4) ↗
- Proteasome subunit alpha type-5 (PSMA5) ↗
- Proteasome subunit alpha type-6 (PSMA6) ↗
- Proteasome subunit alpha type-7 (PSMA7) ↗
- Proteasome subunit beta type-10 (PSMB10) ↗
- Proteasome subunit beta type-11 (PSMB11) ↗
- Proteasome subunit beta type-3 (PSMB3) ↗
- Proteasome subunit beta type-4 (PSMB4) ↗
- Proteasome subunit beta type-7 (PSMB7) ↗
Drugs acting on this target (1)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| marizomib | Inhibitor | experimental | Small molecule | 20S proteosome inhibitor |